152 related articles for article (PubMed ID: 26802029)
1. Imprinting defects at human 14q32 locus alters gene expression and is associated with the pathobiology of osteosarcoma.
Shu J; Li L; Sarver AE; Pope EA; Varshney J; Thayanithy V; Spector L; Largaespada DA; Steer CJ; Subramanian S
Oncotarget; 2016 Apr; 7(16):21298-314. PubMed ID: 26802029
[TBL] [Abstract][Full Text] [Related]
2. An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets.
Hill KE; Kelly AD; Kuijjer ML; Barry W; Rattani A; Garbutt CC; Kissick H; Janeway K; Perez-Atayde A; Goldsmith J; Gebhardt MC; Arredouani MS; Cote G; Hornicek F; Choy E; Duan Z; Quackenbush J; Haibe-Kains B; Spentzos D
J Hematol Oncol; 2017 May; 10(1):107. PubMed ID: 28506242
[TBL] [Abstract][Full Text] [Related]
3. Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma.
Thayanithy V; Sarver AL; Kartha RV; Li L; Angstadt AY; Breen M; Steer CJ; Modiano JF; Subramanian S
Bone; 2012 Jan; 50(1):171-81. PubMed ID: 22037351
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma.
Sarver AL; Thayanithy V; Scott MC; Cleton-Jansen AM; Hogendoorn PC; Modiano JF; Subramanian S
Orphanet J Rare Dis; 2013 Jan; 8():7. PubMed ID: 23311495
[TBL] [Abstract][Full Text] [Related]
5. Imprinting defects in osteosarcoma: DNA- and chromatin-modifying drugs hold promise for osteosarcoma therapy.
Sarver AE; Subramanian S
Epigenomics; 2016 Jul; 8(7):885-8. PubMed ID: 27366930
[No Abstract] [Full Text] [Related]
6. Variants in the 14q32 miRNA cluster are associated with osteosarcoma risk in the Spanish population.
Martin-Guerrero I; Bilbao-Aldaiturriaga N; Gutierrez-Camino A; Santos-Zorrozua B; Dolžan V; Patiño-Garcia A; Garcia-Orad A
Sci Rep; 2018 Oct; 8(1):15414. PubMed ID: 30337581
[TBL] [Abstract][Full Text] [Related]
7. The metastatic behavior of osteosarcoma by gene expression and cytogenetic analyses.
Salinas-Souza C; De Oliveira R; Alves MT; Garcia Filho RJ; Petrilli AS; Toledo SR
Hum Pathol; 2013 Oct; 44(10):2188-98. PubMed ID: 23845465
[TBL] [Abstract][Full Text] [Related]
8. Hypomethylation of the P3 promoter is associated with up-regulation of IGF2 expression in human osteosarcoma.
Li Y; Meng G; Huang L; Guo QN
Hum Pathol; 2009 Oct; 40(10):1441-7. PubMed ID: 19427670
[TBL] [Abstract][Full Text] [Related]
9. Increased Expression of microRNA-199b-5p Associates with Poor Prognosis Through Promoting Cell Proliferation, Invasion and Migration Abilities of Human Osteosarcoma.
Zeng H; Zhang Z; Dai X; Chen Y; Ye J; Jin Z
Pathol Oncol Res; 2016 Apr; 22(2):253-60. PubMed ID: 26183062
[TBL] [Abstract][Full Text] [Related]
10. IRX1 hypomethylation in osteosarcoma metastasis.
Lu J; Wang J
Oncotarget; 2015 Jul; 6(19):16802-3. PubMed ID: 26158902
[No Abstract] [Full Text] [Related]
11. Predictive properties of DNA methylation patterns in primary tumor samples for osteosarcoma relapse status.
Rosenblum JM; Wijetunga NA; Fazzari MJ; Krailo M; Barkauskas DA; Gorlick R; Greally JM
Epigenetics; 2015; 10(1):31-9. PubMed ID: 25531418
[TBL] [Abstract][Full Text] [Related]
12. DLK1-DIO3 imprinted locus deregulation in development, respiratory disease, and cancer.
Enterina JR; Enfield KSS; Anderson C; Marshall EA; Ng KW; Lam WL
Expert Rev Respir Med; 2017 Sep; 11(9):749-761. PubMed ID: 28715922
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-22 acts as an unfavorable prognostic biomarker in osteosarcoma.
Wang G; Shen N; Cheng L; Lin J; Li K
Tumour Biol; 2015 Sep; 36(10):7891-5. PubMed ID: 25953260
[TBL] [Abstract][Full Text] [Related]
14. miRNA-449a is downregulated in osteosarcoma and promotes cell apoptosis by targeting BCL2.
Chen J; Zhou J; Chen X; Yang B; Wang D; Yang P; He X; Li H
Tumour Biol; 2015 Sep; 36(10):8221-9. PubMed ID: 26002578
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of long noncoding RNA CCAL predicts poor patient prognosis and promotes tumor metastasis in osteosarcoma.
Zhou DK; Yang XW; Li H; Yang Y; Zhu ZJ; Wu N
Int J Biol Markers; 2017 Mar; 32(1):e108-e112. PubMed ID: 28009431
[TBL] [Abstract][Full Text] [Related]
16. Maternally inherited deletion encompassing the RTL1as and MEG8 genes of the human 14q32 imprinted region in a patient with a mild Kagami-Ogata syndrome phenotype.
Sirera Sirera P; García-Payá E; Olivas García J; Jadraque Rodríguez R; Hernández Romero SD
Am J Med Genet A; 2023 Aug; 191(8):2225-2231. PubMed ID: 37222159
[TBL] [Abstract][Full Text] [Related]
17. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
Zhu B; Cheng D; Li S; Zhou S; Yang Q
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247
[TBL] [Abstract][Full Text] [Related]
18. Global DNA methylation analysis of human atherosclerotic plaques reveals extensive genomic hypomethylation and reactivation at imprinted locus 14q32 involving induction of a miRNA cluster.
Aavik E; Lumivuori H; Leppänen O; Wirth T; Häkkinen SK; Bräsen JH; Beschorner U; Zeller T; Braspenning M; van Criekinge W; Mäkinen K; Ylä-Herttuala S
Eur Heart J; 2015 Apr; 36(16):993-1000. PubMed ID: 25411193
[TBL] [Abstract][Full Text] [Related]
19. Changes in genomic imprinting and gene expression associated with transformation in a model of human osteosarcoma.
Li Y; Meng G; Guo QN
Exp Mol Pathol; 2008 Jun; 84(3):234-9. PubMed ID: 18501891
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis of imprinting disorders affecting chromosome 14: lessons from murine models.
Howard M; Charalambous M
Reproduction; 2015 May; 149(5):R237-49. PubMed ID: 25820903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
